190 related articles for article (PubMed ID: 28730617)
1. Methotrexate for Severe Childhood Atopic Dermatitis: Clinical Experience in a Tertiary Center.
Dvorakova V; O'Regan GM; Irvine AD
Pediatr Dermatol; 2017 Sep; 34(5):528-534. PubMed ID: 28730617
[TBL] [Abstract][Full Text] [Related]
2. Treatment of severe pediatric atopic dermatitis with methotrexate: A retrospective review.
Anderson K; Putterman E; Rogers RS; Patel D; Treat JR; Castelo-Soccio L
Pediatr Dermatol; 2019 May; 36(3):298-302. PubMed ID: 30811669
[TBL] [Abstract][Full Text] [Related]
3. Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults.
Lyakhovitsky A; Barzilai A; Heyman R; Baum S; Amichai B; Solomon M; Shpiro D; Trau H
J Eur Acad Dermatol Venereol; 2010 Jan; 24(1):43-9. PubMed ID: 19552716
[TBL] [Abstract][Full Text] [Related]
4. Low dose methotrexate therapy is effective in late-onset atopic dermatitis and idiopathic eczema.
Zoller L; Ramon M; Bergman R
Isr Med Assoc J; 2008 Jun; 10(6):413-4. PubMed ID: 18669134
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate for treatment of atopic dermatitis in children and adolescents.
Deo M; Yung A; Hill S; Rademaker M
Int J Dermatol; 2014 Aug; 53(8):1037-41. PubMed ID: 24602088
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial of methotrexate versus azathioprine for severe atopic eczema.
Schram ME; Roekevisch E; Leeflang MM; Bos JD; Schmitt J; Spuls PI
J Allergy Clin Immunol; 2011 Aug; 128(2):353-9. PubMed ID: 21514637
[TBL] [Abstract][Full Text] [Related]
7. The use of methotrexate for treating childhood atopic dermatitis: a multicenter retrospective study.
Taieb Y; Baum S; Ben Amitai D; Barzilai A; Greenberger S
J Dermatolog Treat; 2019 May; 30(3):240-244. PubMed ID: 30109960
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate in the Treatment of Moderate to Severe Atopic Dermatitis: A Retrospective Study.
Shah N; Alhusayen R; Walsh S; Shear NH
J Cutan Med Surg; 2018; 22(5):484-487. PubMed ID: 29855201
[TBL] [Abstract][Full Text] [Related]
9. Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel, SDZ ASM 981): impact on quality of life and health-related quality of life.
McKenna SP; Whalley D; de Prost Y; Staab D; Huels J; Paul CF; van Assche D
J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):248-54. PubMed ID: 16503881
[TBL] [Abstract][Full Text] [Related]
10. Balneotherapy for atopic dermatitis in children at Comano spa in Trentino, Italy.
Farina S; Gisondi P; Zanoni M; Pace M; Rizzoli L; Baldo E; Girolomoni G
J Dermatolog Treat; 2011 Dec; 22(6):366-71. PubMed ID: 21254853
[TBL] [Abstract][Full Text] [Related]
11. Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study.
Peserico A; Städtler G; Sebastian M; Fernandez RS; Vick K; Bieber T
Br J Dermatol; 2008 Apr; 158(4):801-7. PubMed ID: 18284403
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of a cream containing AR-GG27® (sorbityl furfural palmitate) in the treatment of mild/moderate childhood atopic dermatitis associated with pityriasis alba. A double-blind, placebo-controlled clinical trial.
Patrizi A; Raone B; Raboni R; Neri I
G Ital Dermatol Venereol; 2012 Dec; 147(6 Suppl 1):1-8. PubMed ID: 23007324
[TBL] [Abstract][Full Text] [Related]
13. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
[TBL] [Abstract][Full Text] [Related]
14. [Post-marketing surveillance on treatment of 5,665 patients with atopic dermatitis using the calcineurin inhibitor pimecrolimus: positive effects on major symptoms of atopic dermatitis and on quality of life].
Sunderkötter C; Weiss JM; Bextermöller R; Löffler H; Schneider D
J Dtsch Dermatol Ges; 2006 Apr; 4(4):301-6. PubMed ID: 16638059
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis.
Singalavanija S; Noppakun N; Limpongsanuruk W; Wisuthsarewong W; Aunhachoke K; Chunharas A; Wananukul S; Akaraphanth R
J Med Assoc Thai; 2006 Nov; 89(11):1915-22. PubMed ID: 17205874
[TBL] [Abstract][Full Text] [Related]
16. Atopic dermatitis: systemic immunosuppressive therapy.
Akhavan A; Rudikoff D
Semin Cutan Med Surg; 2008 Jun; 27(2):151-5. PubMed ID: 18620137
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate versus cyclosporine in the treatment of severe atopic dermatitis in children: a multicenter experience from Egypt.
El-Khalawany MA; Hassan H; Shaaban D; Ghonaim N; Eassa B
Eur J Pediatr; 2013 Mar; 172(3):351-6. PubMed ID: 23229188
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review.
Roekevisch E; Spuls PI; Kuester D; Limpens J; Schmitt J
J Allergy Clin Immunol; 2014 Feb; 133(2):429-38. PubMed ID: 24269258
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate and azathioprine for severe atopic dermatitis: a 5-year follow-up study of a randomized controlled trial.
Gerbens LAA; Hamann SAS; Brouwer MWD; Roekevisch E; Leeflang MMG; Spuls PI
Br J Dermatol; 2018 Jun; 178(6):1288-1296. PubMed ID: 29237228
[TBL] [Abstract][Full Text] [Related]
20. Long-term effect of methotrexate for childhood atopic dermatitis.
Purvis D; Lee M; Agnew K; Birchall N; Dalziel SR
J Paediatr Child Health; 2019 Dec; 55(12):1487-1491. PubMed ID: 31016803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
